Time:October 29-31, 2019
Country&Region: Spain
Venue:Palau de Congressos de Catalunya
Organizer:Terrapinn Holdings Ltd
The World Vaccine Congress is an award winning series of conferences and an exhibition that has grown to become the largest and most established vaccine meeting of its kind across the globe.
Now in its 20th year the World Vaccine Congress Europe, co-located 5th World Veterinary Vaccine Congress and 4th Immune-Oncology Profiling Congress, will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering.
With 600+ potential customers in attendance there will be opportunities to find contacts who need to find solutions to challenges around the commercial and scientific issues in manufacturing, clinical trials, strategy, regulation, veterinary vaccines, immune profiling, AMR, respiratory, influenza, therapeutic and emerging disease vaccines.
The World Vaccine Congress Europe offers outstanding opportunities for service and solution providers, from senior sponsorship to a range of exhibition booths. If you are looking to gain access to key vaccine decision makers then this is your best ROI in 2019.
Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies
From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast evolving cancer landscape
From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape
Hear from exciting new vaccine biotechs presenting on their pipeline as well as case studies and on how best to form publicprivate partnerships
Find ways to improve development of universal influenza, RSV, MERS and TB vaccines
Understand the opportunities for your business in reacting to global threats like Zika, Malaria, Dengue and Ebola
Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy.
Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies cancer
An entire day dedicated to AMR – how real is the threat? Find out the role of vaccines and all other factors from public health authorities, government agencies, leading vaccine manufacturers and expert physicians for a holistic response strategy
Previous:MEDICAL FAIR THAILAND 2019
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us: